Allergy China Prescription Drug Sales Data 2010
Topics: Prescription Drugs, Pricing
Regions: China
|
Special Report: Opportunities in Emerging Markets—Developing Asia
Topics: International Trade, Research & Development, General Pharmaceuticals, Pharmacy & Distribution, Research & Development, Prescription Drugs
Regions: China, India, Russia
|
Pharmaceuticals - Europe
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs
Regions: Europe
|
Senile Dementia China Prescription Drug Sales Data 2010
Topics: Prescription Drugs, Pricing, CNS/Neurology
|
Benign Prostate China Prescription Drug Sales Data 2010
Topics: Prescription Drugs
Regions: China
|
Pharmaceutical Sales Force Effectiveness - Rethinking the Current Sales Model
Topics: General Pharmaceuticals, Country Overviews, Prescription Drugs
|
Asthmatic China Prescription Drugs Sales Data 2010
Topics: Asthma, Manufacturing, Packaging & Detailing, Prescription Drugs, Pricing
Regions: China
|
Oncology China Prescription Drug Sales Data 2010
Topics: Prescription Drugs, Pricing
Regions: China
|
Rheumatoid Arthritis China Prescription Drug Sales Data 2010
Topics: Prescription Drugs, Pricing, Rheumatology/Arthritis
Regions: China
|
Ophthalmology China Prescription Drug Sales Data 2010
Topics: Prescription Drugs, Ophthalmology
Regions: China
|
Diabetes China Prescription Drug Sales Data 2010
Topics: Diabetes, Prescription Drugs, Pricing
Regions: China
|
Hypertension China Prescription Drug Sales Data 2010
Topics: Hypertension, Prescription Drugs, Pricing
|
Depression China Prescription Drug Sales Data 2010
Topics: Prescription Drugs, Pricing, CNS/Neurology, Behavioral Health
Regions: China
|
The World Pharmaceutical Markets Fact Book 2011
Topics: Healthcare, Regulation & Policy, Research & Development, Prescription Drugs
Regions: Global
|
Avastin (bevacizumab) - Analysis and Market Forecasts from 2016 to 2020
Topics: Prescription Drugs
|
Nexavar - Analysis and Market Forecasts from 2007 to 2020
Topics: Prescription Drugs
|
ThermoDox - Analysis and Market Forecasts from 2012 to 2020
Topics: Prescription Drugs
|
Thalidomide - Analysis and Market Forecasts from 2015 to 2020
Topics: Prescription Drugs
|
Linifanib - Assessment and Market Forecasts from 2013 to 2020
Topics: Pharmaceuticals Company Reports, Prescription Drugs
|
Brivanib - Analysis and Market Forecasts from 2013 to 2020
Topics: Prescription Drugs
|
Doxorubicin - Analysis and Market Forecasts from 2011 to 2020
Topics: Prescription Drugs
|
Muparfostat - Analysis and Market Forecasts from 2017 to 2020
Topics: Prescription Drugs
|
PrevOnco - Analysis and Market Forecasts from 2014 to 2020
Topics: Prescription Drugs
|
Tarceva - Analysis and Market Forecasts from 2013 to 2020
Topics: Prescription Drugs
|
Ramucirumab - Analysis and Market Forecasts from 2014 to 2020
Topics: Prescription Drugs
|
Miripla - Analysis and Market Forecasts from 2010 to 2020
Topics: Prescription Drugs
|
Pharmaceuticals in Germany - Industry and Country Analysis
Topics: Country Overviews, Manufacturing, Packaging & Detailing, Prescription Drugs
|
Gleevec - Analysis and Forecasts from 2013 to 2020
Topics: Prescription Drugs
|
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020
Topics: Prescription Drugs
|
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020
Topics: Prescription Drugs
|
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020
Topics: Prescription Drugs
|
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020
Topics: Prescription Drugs
|
Pharmaceuticals in Denmark - Industry and Country Analysis
Topics: Country Overviews, Prescription Drugs
Regions: Denmark
|
Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020
Topics: Prescription Drugs
|
Riociguat - Analysis and Forecasts from 2013 to 2020
Topics: Prescription Drugs
|
Remodulin - Analysis and Forecasts from 2002 to 2020
Topics: Prescription Drugs
|
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017
Topics: Prescription Drugs
|
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020
Topics: Prescription Drugs
|
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020
Topics: Prescription Drugs
|
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020
Topics: Prescription Drugs
|
Apokyn - Analysis and Estimates from 2004 to 2020
Topics: Prescription Drugs
|
Stalevo - Analysis and Estimates from 2003 to 2020
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs
|
IPX066 - Analysis and Estimates from 2013 to 2020
Topics: Prescription Drugs
|
Safinamide - Analysis and Estimates from 2012 to 2020
Topics: Prescription Drugs
|
Comtan - Analysis and Estimates from 2002 to 2020
Topics: Prescription Drugs
|
Azilect - Analysis and Estimates from 2005 to 2020
Topics: Prescription Drugs
|
Pardoprunox - Analysis and Forecasts from 2013 to 2020
Topics: Prescription Drugs
|
Tasmar - Analysis and Estimates from 2004 to 2020
Topics: Prescription Drugs
|
Mirapex - Analysis and Estimates from 2002 to 2020
Topics: Prescription Drugs
|
Neupro - Analysis and Estimates from 2006 to 2020
Topics: Prescription Drugs
|
